213 related articles for article (PubMed ID: 30349952)
1. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
Tanaka M; Shibahara J; Ishikawa S; Ushiku T; Morikawa T; Shinozaki-Ushiku A; Hayashi A; Misumi K; Tanaka A; Katoh H; Sakuma K; Kokudo T; Inagaki Y; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
Virchows Arch; 2019 Jan; 474(1):39-46. PubMed ID: 30349952
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.
Sarcognato S; Gringeri E; Fassan M; Di Giunta M; Maffeis V; Guzzardo V; Cillo U; Guido M
Virchows Arch; 2019 Jan; 474(1):29-37. PubMed ID: 30377796
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.
Misumi K; Hayashi A; Shibahara J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M
Histopathology; 2017 Apr; 70(5):766-774. PubMed ID: 27864835
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of G
Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784
[TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
Schlitter AM; Born D; Bettstetter M; Specht K; Kim-Fuchs C; Riener MO; Jeliazkova P; Sipos B; Siveke JT; Terris B; Zen Y; Schuster T; Höfler H; Perren A; Klöppel G; Esposito I
Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
[TBL] [Abstract][Full Text] [Related]
6. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
[TBL] [Abstract][Full Text] [Related]
7. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
[TBL] [Abstract][Full Text] [Related]
8. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
Aishima S; Kuroda Y; Nishihara Y; Iguchi T; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
[TBL] [Abstract][Full Text] [Related]
9. Histopathological evidence of neoplastic progression of von Meyenburg complex to intrahepatic cholangiocarcinoma.
Bhalla A; Mann SA; Chen S; Cummings OW; Lin J
Hum Pathol; 2017 Sep; 67():217-224. PubMed ID: 28823571
[TBL] [Abstract][Full Text] [Related]
10. Pathological characteristics of intraductal polypoid neoplasms of bile ducts in Thailand.
Nitta T; Nakanuma Y; Sato Y; Hirano S; Pairojkul C
Int J Clin Exp Pathol; 2015; 8(7):8284-90. PubMed ID: 26339398
[TBL] [Abstract][Full Text] [Related]
11. Distinct Clinicopathologic and Genetic Features of 2 Histologic Subtypes of Intrahepatic Cholangiocarcinoma.
Hayashi A; Misumi K; Shibahara J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M
Am J Surg Pathol; 2016 Aug; 40(8):1021-30. PubMed ID: 27259014
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.
Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK
Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731
[TBL] [Abstract][Full Text] [Related]
13. The Role of DNA Repair Glycosylase OGG1 in Intrahepatic Cholangiocarcinoma.
Sakata K; Yoshizumi T; Izumi T; Shimokawa M; Itoh S; Ikegami T; Harada N; Toshima T; Mano Y; Mori M
Anticancer Res; 2019 Jun; 39(6):3241-3248. PubMed ID: 31177174
[TBL] [Abstract][Full Text] [Related]
14. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
16. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns.
Sigel CS; Drill E; Zhou Y; Basturk O; Askan G; Pak LM; Vakiani E; Wang T; Boerner T; Do RKG; Simpson AL; Jarnagin W; Klimstra DS
Am J Surg Pathol; 2018 Oct; 42(10):1334-1345. PubMed ID: 30001234
[TBL] [Abstract][Full Text] [Related]
18. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
[TBL] [Abstract][Full Text] [Related]
19. Tumor Budding in Intrahepatic Cholangiocarcinoma: A Predictor of Postsurgery Outcomes.
Tanaka M; Yamauchi N; Ushiku T; Shibahara J; Hayashi A; Misumi K; Yasunaga Y; Morikawa T; Kokudo T; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
Am J Surg Pathol; 2019 Sep; 43(9):1180-1190. PubMed ID: 31335353
[TBL] [Abstract][Full Text] [Related]
20. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
Imai K; Yamamoto M; Ariizumi S
Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]